- Home
- ESLA vs CULP Comparison
ESLA vs CULP Comparison
Compare ESLA & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESLA
- CULP
- Stock Information
- Founded
- ESLA 2021
- CULP 1972
- Country
- ESLA United States
- CULP United States
- Employees
- ESLA N/A
- CULP N/A
- Industry
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- CULP Textiles
- Sector
- ESLA Health Care
- CULP Consumer Discretionary
- Exchange
- ESLA Nasdaq
- CULP Nasdaq
- Market Cap
- ESLA 48.9M
- CULP 52.7M
- IPO Year
- ESLA N/A
- CULP N/A
- Fundamental
- Price
- ESLA $2.92
- CULP $3.81
- Analyst Decision
- ESLA Strong Buy
- CULP
- Analyst Count
- ESLA 1
- CULP 0
- Target Price
- ESLA $16.00
- CULP N/A
- AVG Volume (30 Days)
- ESLA 492.9K
- CULP 16.1K
- Earning Date
- ESLA 11-13-2025
- CULP 12-03-2025
- Dividend Yield
- ESLA N/A
- CULP N/A
- EPS Growth
- ESLA N/A
- CULP N/A
- EPS
- ESLA N/A
- CULP N/A
- Revenue
- ESLA N/A
- CULP $207,391,000.00
- Revenue This Year
- ESLA N/A
- CULP $1.93
- Revenue Next Year
- ESLA N/A
- CULP $2.77
- P/E Ratio
- ESLA N/A
- CULP N/A
- Revenue Growth
- ESLA N/A
- CULP N/A
- 52 Week Low
- ESLA $0.70
- CULP $3.42
- 52 Week High
- ESLA $3.15
- CULP $5.94
- Technical
- Relative Strength Index (RSI)
- ESLA 65.89
- CULP 27.51
- Support Level
- ESLA $2.20
- CULP $3.95
- Resistance Level
- ESLA $3.15
- CULP $4.05
- Average True Range (ATR)
- ESLA 0.43
- CULP 0.12
- MACD
- ESLA 0.03
- CULP -0.03
- Stochastic Oscillator
- ESLA 83.21
- CULP 3.09
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About CULP Culp Inc.
Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.